Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Johnson & Johnson (J&J) is a holding company that manufactures and sells a broad range of products in pharmaceutical, consumer and medical fields. Its product offerings include drugs to treat immune disorders, neurological diseases, cancer, cardiovascular problems and metabolism disorders; medical products used in orthopedics, surgery, cardiovascular, diabetes care and vision care fields; and consumer products comprising health and personal care products in beauty, skin care, nutritional, oral care, baby care, women’s health and over-the-counter, and wellness and prevention categories. It has research facilities in the US, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the UK. The company conducts its operations through subsidiaries the world over. J&J is headquartered in New Brunswick, New Jersey, the US.
Johnson & Johnson Key Recent Developments
Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results
Jul 13, 2016: Ethicon Study: Bariatric Surgery Found To Be A More Effective Way To Control Diabetes In Obese Asian Indian Patients
Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations
Jun 06, 2016: GHIT Fund Welcomes Ten New Partnerships With FUJIFILM, Otsuka, GSK, Johnson & Johnson, Kyowa Hakko Kirin, Merck, Mitsubishi Tanabe, Nipro, Sumitomo Dainippon Pharma and Salesforce.com
May 18, 2016: Johnson & Johnson Showcasing its Broad Innovation and Technology Strategies in Consumer and Medical Device Businesses
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Johnson & Johnson - Key Facts 6
Johnson & Johnson - Key Employees 7
Johnson & Johnson - Key Employee Biographies 8
Johnson & Johnson - Major Products and Services 9
Johnson & Johnson - Pharmaceutical Pipeline Products Data 12
Johnson & Johnson, Pipeline Products by Therapy Area 12
Johnson & Johnson, Pipeline Products by Development Phase 13
Johnson & Johnson - History 24
Johnson & Johnson - Company Statement 39
Johnson & Johnson - Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Section 2 – Company Analysis 62
Johnson & Johnson - Business Description 62
Business Description - Consumer 62
Consumer - Overview 62
Consumer - Financials 62
Business Description - Medical Devices 62
Medical Devices - Overview 62
Medical Devices - Financials 63
Business Description - Pharmaceutical 63
Pharmaceutical - Overview 63
Pharmaceutical - Financials 64
Johnson & Johnson - Corporate Strategy 65
Johnson & Johnson - SWOT Analysis 66
SWOT Analysis - Overview 66
Johnson & Johnson - Strengths 66
Strength - Pharmaceutical Segment 66
Strength - In-house Research Capabilities 66
Strength - Strategic Acquisitions 66
Johnson & Johnson - Weaknesses 68
Weakness - Declining Performance of Medical Devices 68
Weakness - Patent Infringements and Other Disputes 68
Weakness - Market Exclusivity Concerns 68
Johnson & Johnson - Opportunities 69
Opportunity - New Product Approvals in Orthopedic Franchise 69
Opportunity - Pharmaceutical Pipeline 69
Opportunity - Strategic Initiatives 69
Johnson & Johnson - Threats 71
Threat - Stiff Competition 71
Threat - Stringent Regulations 71
Threat - Rise of Generics 71
Johnson & Johnson - Key Competitors 72
Section 3 – Company Financial Ratios 73
Financial Ratios - Capital Market Ratios 73
Financial Ratios - Annual Ratios 74
Performance Chart 76
Financial Performance 76
Financial Ratios - Interim Ratios 77
Financial Ratios - Ratio Charts 78
Section 4 – Company’s Lifesciences Financial Deals and Alliances 79
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 79
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 80
Johnson & Johnson, Medical Equipment, Deals By Year, 2010 to YTD 2016 81
Johnson & Johnson, Medical Equipment, Deals By Type, 2010 to YTD 2016 82
Johnson & Johnson, Recent Deals Summary 83
Section 5 – Company’s Recent Developments 84
Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results 84
Jul 13, 2016: Ethicon Study: Bariatric Surgery Found To Be A More Effective Way To Control Diabetes In Obese Asian Indian Patients 86
Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations 87
Jun 06, 2016: GHIT Fund Welcomes Ten New Partnerships With FUJIFILM, Otsuka, GSK, Johnson & Johnson, Kyowa Hakko Kirin, Merck, Mitsubishi Tanabe, Nipro, Sumitomo Dainippon Pharma and Salesforce.com 88
May 18, 2016: Johnson & Johnson Showcasing its Broad Innovation and Technology Strategies in Consumer and Medical Device Businesses 90
Apr 19, 2016: Johnson & Johnson Reports 2016 First-Quarter Results 92
Apr 05, 2016: Johnson & Johnson Announces Launch of New Global Public Health Strategy at Opening of New Operations in Africa 94
Mar 14, 2016: DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent Infringement 96
Feb 29, 2016: Baron & Budd Investigating Potential Lawsuits Against Johnson & Johnson Regarding Link Between Talcum Powder and Ovarian Cancer 97
Feb 17, 2016: Johnson & Johnson Issues Call for Innovative Ideas to Reduce HIV Infections in Sub-Saharan Africa 98
Section 6 – Appendix 99
Methodology 99
Ratio Definitions 99
About GlobalData 103
Contact Us 103
Disclaimer 103
List of Tables
Johnson & Johnson, Key Facts 6
Johnson & Johnson, Key Employees 7
Johnson & Johnson, Key Employee Biographies 8
Johnson & Johnson, Major Products and Services 9
Johnson & Johnson, Number of Pipeline Products by Therapy Area 12
Johnson & Johnson, Number of Pipeline Products by Development Stage 13
Johnson & Johnson, Pipeline Products By Therapy Area and Development Phase 14
Johnson & Johnson, History 24
Johnson & Johnson, Subsidiaries 41
Johnson & Johnson, Key Competitors 72
Johnson & Johnson, Ratios based on current share price 73
Johnson & Johnson, Annual Ratios 74
Johnson & Johnson, Interim Ratios 77
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 79
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 80
Johnson & Johnson, Medical Equipment, Deals By Year, 2010 to YTD 2016 81
Johnson & Johnson, Medical Equipment, Deals By Type, 2010 to YTD 2016 82
Johnson & Johnson, Recent Deals Summary 83
Currency Codes 99
Capital Market Ratios 99
Equity Ratios 100
Profitability Ratios 100
Cost Ratios 101
Liquidity Ratios 101
Leverage Ratios 102
Efficiency Ratios 102
List of Figures
Johnson & Johnson, Pipeline Products by Therapy Area 12
Johnson & Johnson, Pipeline Products by Development Phase 13
Johnson & Johnson, Performance Chart (2011 - 2015) 76
Johnson & Johnson, Ratio Charts 78
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 79
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 80
Johnson & Johnson, Medical Equipment, Deals By Year, 2010 to YTD 2016 81
Johnson & Johnson, Medical Equipment, Deals by Type, 2010 to YTD 2016 82
